Company Filing History:
Years Active: 2020
Title: Thomas Schwarz: Innovator in Pharmaceutical Chemistry
Introduction
Thomas Schwarz is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. His work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Thomas Schwarz holds a patent for a compound known as 2-amino-N-[7-methoxy-2, 3-dihydroimidazo-[1,2-c] quinazolin-5-yl] pyrimidine-5-carboxamides. This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds. The pharmaceutical compositions containing these compounds are designed for phosphatidylinositol-3-kinase (PI3K) inhibition. This innovation aims to treat diseases associated with PI3K activity, particularly hyper-proliferative and/or angiogenesis disorders, either as a sole agent or in combination with other active ingredients.
Career Highlights
Thomas Schwarz is currently employed at Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His role involves research and development of new therapeutic agents that can significantly impact patient care and treatment outcomes. His dedication to advancing medical science is evident in his innovative work.
Collaborations
Thomas has collaborated with esteemed colleagues, including Ningshu Liu and Oliver Politz. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking discoveries in the pharmaceutical field.
Conclusion
In summary, Thomas Schwarz is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for various diseases. His innovative approach and dedication to research continue to make a significant impact in the medical community.